This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Securities

Jul. 16, 2025

12 firms vie for lead counsel in Iovance stock drop lawsuit

Twelve firms compete for lead counsel in Iovance Biotherapeutics securities lawsuit, citing large settlements and client losses after a 44% stock drop due to misleading revenue forecasts.

Twelve firms are battling to be appointed lead counsel in a putative securities class action accusing Iovance Biotherapeutics of causing its stock price to drop 44% in a single day by misrepresenting the anticipated demand for one of its cancer treatments.

In the competing motions filed Monday, some of the firms cited their history of securing large settlements on behalf of investors to sway U.S. District Judge Eumi K. Lee in San Jose. Others claimed their clients' sizable lo...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up